STAT3 and Alzheimer disease: Taken together, these findings reveal strong DN effects, cell-surface GP130 accumulation, and impaired IL-6–induced STAT3 phosphorylation at the border between the 640* and 641* mutations, indicating that the boundary between AR- and AD-IL6ST mutations might exist in this region.